Evogene Ltd. (EVGN) NASDAQ
0.59
-0.0929(-13.60%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.59
-0.0929(-13.60%)
Currency In USD
| Market Cap | 8.66M |
| Enterprise Value | -2.1M |
| P/E Ratio | -0.49 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 2.78 |
| Price/Book Ratio | -2.26 |
| Enterprise/Revenue | -0.77 |
| Enterprise/EBITDA | 0.12 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -6.39 |
| Operating Margin | -7.57 |
| Return On Assets | -0.65 |
| Return On Equity | 9.35 |
| Revenue | 3.85M |
| Revenue/Share | 0.19 |
| Gross Profit | -241,000 |
| EBITDA | -12.2M |
| Net Income | -8.49M |
| Diluted EPS | -1.08 |
| Total Cash | 13.09M |
| Total Cash/Share | 1.35 |
| Total Debt | 2.03M |
| Total Debt/Equity | -0.8 |
| Current Ratio | 2.79 |
| Book Value Per Share | 1.15 |
| 52-Week Change | -45.86 |
| 52-Week High | 2.42 |
| 52-Week Low | 0.52 |
| Moving Average 50 Days | 0.78 |
| Moving Average 200 Days | 1.03 |
| Average Volume | 100,434 |
| Shares Outstanding | 8.62M |
| % Held by Institutions | 7.75 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.02 |
| Last Split Factor | 1:10 |
| Last Split Date | July 25, 2024 |